halcinonide — CareFirst (Caremark)

Initial criteria

• Authorization may be granted when the requested drug is being prescribed for a corticosteroid-responsive dermatosis or condition (e.g., atopic dermatitis, eczema, psoriasis, seborrheic dermatitis) when the following criterion is met:
• • The requested drug is NOT being used in a footbath.

Approval duration

6 months